BMJ Group: GLP-1 Diabetes Drugs Linked to Reduced Risk of Addiction and Substance-Related Death
March 05, 2026
March 05, 2026
LONDON, England, March 5 (TNSjou) -- BMJ Group issued the following news release about The BMJ:
* * *
GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death
Findings suggest a potential role in both prevention and treatment of various substance use disorders, say researchers
*
Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of . . .
* * *
GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death
Findings suggest a potential role in both prevention and treatment of various substance use disorders, say researchers
*
Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of . . .